DERL2 Polyclonal Antibody

Proteins that are unfolded or misfolded in the endoplasmic reticulum (ER) must be refolded or degraded to maintain the homeostasis of the ER. DERL2 is involved in the degradation of misfolded glycoproteins in the ER (Oda et al., 2006

The DERL2 Polyclonal Antibody is a highly reliable and efficient tool designed for various applications in the field of molecular biology. This antibody is specifically developed to target DERL2, a protein involved in the endoplasmic reticulum-associated degradation pathway. With its exceptional specificity and sensitivity, this polyclonal antibody enables accurate detection and quantification of DERL2 in a wide range of samples.

The DERL2 Polyclonal Antibody exhibits outstanding performance in Western blotting, immunohistochemistry, and immunofluorescence assays. Its superior affinity and selectivity ensure precise and reproducible results, making it an ideal choice for researchers and scientists working in diverse areas such as protein degradation, cellular stress response, and protein quality control.

This antibody is produced using advanced recombinant DNA technology, ensuring high purity and batch-to-batch consistency. It is rigorously validated to meet the highest quality standards, guaranteeing reliable and reproducible results in every experiment. The DERL2 Polyclonal Antibody is supplied in a convenient and user-friendly format, allowing for easy handling and storage.

In summary, the DERL2 Polyclonal Antibody is a top-tier research tool that offers exceptional performance and reliability. Its ability to accurately detect and quantify DERL2 makes it an invaluable asset for scientists and researchers seeking to unravel the intricate mechanisms of protein degradation and quality control.